Blaž Rozman

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

A. J. Tyndall, Bettina Bannert, Paolo Airó et al. · Annals of the Rheumatic Diseases · 2010 · 1.4K citations · Full text

Public Health, Biostatistics, Cardiology +14

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

Barry Bresnihan, Jos� Maria Alvaro-Gracia, Mark Cobby et al. · Arthritis & Rheumatism · 1998 · 974 citations

Medicine, Immunology, Pharmacotherapy +16

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

Josef S Smolen, Joachim R. Kalden, David L. Scott et al. · The Lancet · 1999 · 773 citations

Medicine, Pharmacology, Pharmacotherapy +10

Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines

Alenka Kužnik, Mojca Benčina, Urban Švajger et al. · The Journal of Immunology · 2011 · 610 citations · Full text

Life Sciences, Immunology, Pharmacology +13

Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis

Vlastimir Mladenovic, Z Domljan, Blaž Rozman et al. · Arthritis & Rheumatism · 1995 · 306 citations

Medicine, Pharmacology, Pharmacotherapy +13